ANEBULO PHARMAC. DL-,001 earnings per share and revenue

214 earnings per share for the last quarter are -0.07 EUR whereas the estimation was -0.04 EUR which accounts for -60.00% surprise. Company revenue for the same period amounts to 0.00 EUR despite the estimated figure of 0.00 EUR. Estimated earnings per share for the next quarter are -0.08 EUR, and revenue is expected to reach 0.00 EUR. Also watch annual changes over time to get a bigger picture of 214 earnings per share and revenue dynamics.